As of Jun 23
| -1.32 / -0.76%|
The 20 analysts offering 12-month price forecasts for Amgen have a median target of 182.50, with a high estimate of 209.00 and a low estimate of 161.00. The median estimate represents a +5.80% increase from the last price of 172.50.
The current consensus among 25 polled investment analysts is to Hold stock in Amgen. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.